Colgate-Palmolive Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Colgate-Palmolive wird ein jährliches Gewinn- und Umsatzwachstum von 7.8% bzw. 3.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 140.7% betragen.
Wichtige Informationen
7.8%
Wachstumsrate der Gewinne
9.0%
EPS-Wachstumsrate
| Household Products Gewinnwachstum | 7.5% |
| Wachstumsrate der Einnahmen | 3.8% |
| Zukünftige Eigenkapitalrendite | 140.7% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 09 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06
Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly
Jun 05Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)
May 18Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Feb 23Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)
Feb 05What to expect from Colgate-Palmolive's Q4 2022 Earnings
Jan 26Colgate-Palmolive declares $0.47 dividend
Jan 12Lorrie Norrington named lead independent director of Colgate
Jan 03Colgate-Palmolive (NYSE:CL) Will Be Hoping To Turn Its Returns On Capital Around
Jan 01Colgate-Palmolive: I Like The Toothpaste But Not The Stock
Dec 22Colgate-Palmolive: Good Long-Term Prospects But Fairly Valued
Dec 07Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Nov 16Colgate-Palmolive Q3 2022 Earnings Preview
Oct 27Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 21,950 | 3,386 | 3,669 | 4,421 | 12 |
| 12/31/2025 | 21,045 | 3,135 | 3,421 | 4,163 | 18 |
| 12/31/2024 | 20,217 | 2,888 | 3,340 | 3,894 | 18 |
| 3/31/2024 | 19,752 | 2,611 | 3,023 | 3,691 | N/A |
| 12/31/2023 | 19,457 | 2,300 | 3,040 | 3,745 | N/A |
| 9/30/2023 | 19,136 | 1,587 | 2,553 | 3,282 | N/A |
| 6/30/2023 | 18,676 | 1,497 | 2,356 | 3,099 | N/A |
| 3/31/2023 | 18,338 | 1,598 | 2,168 | 2,905 | N/A |
| 12/31/2022 | 17,967 | 1,785 | 1,860 | 2,556 | N/A |
| 9/30/2022 | 17,741 | 1,928 | 2,321 | 2,989 | N/A |
| 6/30/2022 | 17,700 | 1,944 | 2,384 | 3,014 | N/A |
| 3/31/2022 | 17,476 | 2,044 | 2,531 | 3,113 | N/A |
| 12/31/2021 | 17,421 | 2,166 | 2,758 | 3,325 | N/A |
| 9/30/2021 | 17,342 | 2,665 | 2,647 | 3,182 | N/A |
| 6/30/2021 | 17,081 | 2,729 | 2,662 | 3,150 | N/A |
| 3/31/2021 | 16,718 | 2,661 | 3,114 | 3,549 | N/A |
| 12/31/2020 | 16,471 | 2,695 | 3,309 | 3,719 | N/A |
| 9/30/2020 | 16,162 | 2,691 | 3,368 | 3,726 | N/A |
| 6/30/2020 | 15,937 | 2,571 | 3,330 | 3,678 | N/A |
| 3/31/2020 | 15,906 | 2,522 | 2,950 | 3,296 | N/A |
| 12/31/2019 | 15,693 | 2,367 | 2,798 | 3,133 | N/A |
| 9/30/2019 | 15,489 | 2,330 | 2,684 | 3,025 | N/A |
| 6/30/2019 | 15,406 | 2,275 | 2,642 | 3,008 | N/A |
| 3/31/2019 | 15,426 | 2,326 | 2,656 | 3,045 | N/A |
| 12/31/2018 | 15,544 | 2,400 | 2,620 | 3,056 | N/A |
| 9/30/2018 | 15,625 | 2,117 | 2,461 | 2,953 | N/A |
| 6/30/2018 | 15,754 | 2,201 | 2,506 | 3,046 | N/A |
| 3/31/2018 | 15,694 | 2,088 | 2,429 | 2,979 | N/A |
| 12/31/2017 | 15,454 | 2,024 | N/A | 3,054 | N/A |
| 9/30/2017 | 15,283 | 2,307 | N/A | 3,119 | N/A |
| 6/30/2017 | 15,176 | 2,402 | N/A | 3,126 | N/A |
| 3/31/2017 | 15,195 | 2,478 | N/A | 3,218 | N/A |
| 12/31/2016 | 15,195 | 2,441 | N/A | 3,141 | N/A |
| 9/30/2016 | 15,373 | 2,461 | N/A | 3,158 | N/A |
| 6/30/2016 | 15,505 | 2,485 | N/A | 3,046 | N/A |
| 3/31/2016 | 15,726 | 2,459 | N/A | 2,836 | N/A |
| 12/31/2015 | 16,034 | 2,468 | N/A | 2,949 | N/A |
| 9/30/2015 | 16,356 | 2,470 | N/A | 3,014 | N/A |
| 6/30/2015 | 16,736 | 2,286 | N/A | 3,132 | N/A |
| 3/31/2015 | 17,022 | 2,334 | N/A | 3,205 | N/A |
| 12/31/2014 | 17,277 | 2,180 | N/A | 3,298 | N/A |
| 9/30/2014 | 17,417 | 2,116 | N/A | 3,231 | N/A |
| 6/30/2014 | 17,436 | 2,230 | N/A | 3,268 | N/A |
| 3/31/2014 | 17,430 | 2,169 | N/A | 3,247 | N/A |
| 12/31/2013 | 17,420 | 2,241 | N/A | 3,204 | N/A |
| 9/30/2013 | 17,345 | 2,275 | N/A | 3,428 | N/A |
| 6/30/2013 | 17,279 | 2,273 | N/A | 3,328 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CLDas prognostizierte Gewinnwachstum (7.8% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: CLDie Erträge des Unternehmens (7.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: CLDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: CLDie Einnahmen des Unternehmens (3.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: CLDie Einnahmen des Unternehmens (3.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CLDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (140.7%).